179 filings
Page 3 of 9
8-K
aaf1ah23
4 Jun 21
Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:48pm
8-K
5k1cea
7 May 21
Ocuphire Announces Financial Results for the First Quarter 2021 and Provides Corporate Update
4:01pm
8-K
etbo5z
12 Apr 21
Other Events
4:20pm
8-K
85sul
15 Mar 21
Regulation FD Disclosure
9:00am
8-K
kpmwwr1e0sk u561
11 Mar 21
Ocuphire Announces Financial Results for the Full Year 2020 and Provides Corporate Update
9:12am
8-K
e5glyby9evje rx
11 Mar 21
Entry into a Material Definitive Agreement
8:34am
8-K
11j5eg1xxj17m
4 Feb 21
Entry into a Material Definitive Agreement
12:00am
8-K
5grlo
6 Jan 21
Ocuphire Corporate Presentation January 2021
7:37am
8-K/A
u4tgz
30 Dec 20
Financial Statements and Exhibits
5:13pm
8-K
3m1ck6w
25 Nov 20
Entry into a Material Definitive Agreement
4:30pm
8-K
s2cgzyht2ycn
17 Nov 20
Departure of Directors or Certain Officers
4:44pm
8-K
27151vf
6 Nov 20
Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
9:18am
8-K
je2jbev2sayf
3 Nov 20
Rexahn Pharmaceuticals Announces Stockholder Approval of All Proposals Required for Merger with Ocuphire Pharma
6:06am
8-K
lcd5fzw6 3f3dks7d
9 Oct 20
Other Events
4:03pm
8-K
6ykha rhk4gv
11 Sep 20
Entry into a Material Definitive Agreement
6:45am
8-K
yh8xs9zm3o
2 Sep 20
Entry into a Material Definitive Agreement
7:00am
8-K
u6rjp84bmp
3 Aug 20
Entry into a Material Definitive Agreement
7:30am
8-K
sm68 1l1gl
1 Jul 20
Entry into a Material Definitive Agreement
8:37am
8-K
xqkm631st5
19 Jun 20
Rexahn and Ocuphire Enter into Definitive Merger Agreement
9:02am
8-K
hgu g0dwl37ffdcctc
9 Apr 20
Termination of a Material Definitive Agreement
6:15am